These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

562 related articles for article (PubMed ID: 23927909)

  • 21. [Prospective study on the prevention of heterotopic ossification after total hip replacement. Non-steroidal anti-inflammatory agents versus radiation therapy].
    Kölbl O; Flentje M; Eulert J; Barthel T; Knelles D; Kraus U
    Strahlenther Onkol; 1997 Dec; 173(12):677-82. PubMed ID: 9454352
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [External radiotherapy or non-steroidal anti-inflammatory drugs for prevention of heterotopic ossification following total hip replacement].
    Zouhair A; Ozsahin M; Mouhsine E; Leyvraz PF; Mirimanoff RO; Coucke PA
    Schweiz Med Wochenschr; 1999 Mar; 129(9):370-6. PubMed ID: 10198948
    [TBL] [Abstract][Full Text] [Related]  

  • 23. External beam radiation helps prevent heterotopic bone formation in patients with a history of heterotopic ossification.
    Chao ST; Lee SY; Borden LS; Joyce MJ; Krebs VE; Suh JH
    J Arthroplasty; 2006 Aug; 21(5):731-6. PubMed ID: 16877161
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Preoperative irradiation versus the use of nonsteroidal anti-inflammatory drugs for prevention of heterotopic ossification following total hip replacement: the results of a randomized trial.
    Kölbl O; Knelles D; Barthel T; Raunecker F; Flentje M; Eulert J
    Int J Radiat Oncol Biol Phys; 1998 Sep; 42(2):397-401. PubMed ID: 9788422
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Short-course indomethacin prevents heterotopic ossification in a high-risk population following total hip arthroplasty.
    Amstutz HC; Fowble VA; Schmalzried TP; Dorey FJ
    J Arthroplasty; 1997 Feb; 12(2):126-32. PubMed ID: 9139094
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Selective COX-2 Inhibitors Significantly Reduce the Occurrence of Heterotopic Ossification After Hip Arthroscopic Surgery.
    Rath E; Warschawski Y; Maman E; Dolkart O; Sharfman ZT; Salai M; Amar E
    Am J Sports Med; 2016 Mar; 44(3):677-81. PubMed ID: 26695395
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Selective COX-2 inhibitor versus indomethacin for the prevention of heterotopic ossification after hip replacement: a double-blind randomized trial of 100 patients with 1-year follow-up.
    Grohs JG; Schmidt M; Wanivenhaus A
    Acta Orthop; 2007 Feb; 78(1):95-8. PubMed ID: 17453399
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparative clinical study of the prophylaxis of heterotopic ossifications after total hip arthroplasty using etoricoxib or diclofenac.
    Winkler S; Springorum HR; Vaitl T; Handel M; Barta S; Kehl V; Craiovan B; Grifka J
    Int Orthop; 2016 Apr; 40(4):673-80. PubMed ID: 26728611
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prophylaxis of heterotopic ossification after total hip arthroplasty: a prospective randomized study comparing indomethacin and meloxicam.
    Barthel T; Baumann B; Nöth U; Eulert J
    Acta Orthop Scand; 2002 Dec; 73(6):611-4. PubMed ID: 12553505
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Heterotopic ossification after total hip arthroplasty: risk factors and prevention.
    Vastel L; Kerboull L; Anract P; Kerboull M
    Rev Rhum Engl Ed; 1998 Apr; 65(4):238-44. PubMed ID: 9599792
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Heterotopic ossification after 2-incision total hip arthroplasty.
    Bal BS; Lowe JA; E Gietler A; Aleto TJ
    J Arthroplasty; 2010 Jun; 25(4):538-40. PubMed ID: 19497706
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Incidence of heterotopic ossification and effects of various prophylactic methods after hip resurfacing.
    Le Duff MJ; Takamura KB; Amstutz HC
    Bull NYU Hosp Jt Dis; 2011; 69 Suppl 1():S36-41. PubMed ID: 22035483
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Is etoricoxib effective in preventing heterotopic ossification after primary total hip arthroplasty?
    Brunnekreef JJ; Hoogervorst P; Ploegmakers MJ; Rijnen WH; Schreurs BW
    Int Orthop; 2013 Apr; 37(4):583-7. PubMed ID: 23359100
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cost of radiotherapy versus NSAID administration for prevention of heterotopic ossification after total hip arthroplasty.
    Strauss JB; Chen SS; Shah AP; Coon AB; Dickler A
    Int J Radiat Oncol Biol Phys; 2008 Aug; 71(5):1460-4. PubMed ID: 18234435
    [TBL] [Abstract][Full Text] [Related]  

  • 35. No difference between two doses of diclofenac in prophylaxis of heterotopic ossifications after total hip arthroplasty.
    Sell S; Phillips O; Handel M
    Acta Orthop Scand; 2004 Feb; 75(1):45-9. PubMed ID: 15022805
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Periarticular infiltration in total hip replacement: effect on heterotopic ossification, analgesic requirements and outcome.
    Scott CE; Streit J; Biant LC; Breusch SJ
    Arch Orthop Trauma Surg; 2012 May; 132(5):703-9. PubMed ID: 22222642
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Stable bony integration with and without short-term indomethacin prophylaxis. A 5-year follow-up.
    Trnka HJ; Zenz P; Zembsch A; Easley M; Ritschl P; Salzer M
    Arch Orthop Trauma Surg; 1999; 119(7-8):456-60. PubMed ID: 10613239
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Heterotopic ossification after total hip arthroplasty.
    Cohn RM; Schwarzkopf R; Jaffe F
    Am J Orthop (Belle Mead NJ); 2011 Nov; 40(11):E232-5. PubMed ID: 22263220
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Acute revision hip arthroplasty: a previously unrecognized risk factor for heterotopic ossification.
    Aljurayyan A; Tanzer D; Tanzer M
    Eur J Orthop Surg Traumatol; 2016 Feb; 26(2):183-8. PubMed ID: 26724809
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Selective COX-2 inhibitor versus nonselective COX-1 and COX-2 inhibitor in the prevention of heterotopic ossification after total hip arthroplasty: a meta-analysis of randomised trials].
    Xu BG; Xue DT; Wang XH; Yan SG
    Zhongguo Gu Shang; 2014 Jul; 27(7):609-14. PubMed ID: 25338452
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 29.